Nathan Alyesh

Nathan Alyesh practices at Providence Cedars-Sinai Tarzana Medical Center in Tarzana, California, part of Providence Health & Services.

Nathan Alyesh's NPI, 1417362856, was assigned on June 24, 2014. Nathan Alyesh holds California license A146154.

Nathan Alyesh's primary practice is Providence Cedars-Sinai Tarzana Medical Center, at 18321 Clark Street, Tarzana, CA 91356 in Los Angeles County. The practice phone is (818) 881-0800.

Nathan Alyesh's primary practice is Providence Cedars-Sinai Tarzana Medical Center in Tarzana, California, part of Providence Health & Services. The medical group on file is Cedars-Sinai Medical Group. Dmand AI also links Nathan Alyesh to 1 more physician office, 1 home health agency and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Nathan Alyesh practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Nathan Alyesh's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Nathan Alyesh is licensed in California.

CMS data shows 828 Medicare services from Nathan Alyesh across 6 procedure codes in 2024, for 281 Medicare patients. Medicare paid $78,273 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 281 Medicare patients who saw Nathan Alyesh in 2024. The largest group is 75 to 84, with 124 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 2.21, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Nathan Alyesh's median patient age at 73, with 52% women.

In 2024, Nathan Alyesh wrote 825 Medicare Part D claims for 244 patients. 90% of them were for generic drugs. CMS names the drug for 484 of them, across 27 drugs with 11 or more claims each, at $34,990 in total drug cost. In 2023, CMS named 430 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Nathan Alyesh for performance year 2024, reported as part of a group. Nathan Alyesh accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 8 general payments to Nathan Alyesh from 6 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) paid the most, $125.